T-type Ca2+ channel blockers prevent cardiac cell hypertrophy through an inhibition of calcineurin-NFAT3 activation as well as L-type Ca2+ channel blockers.
about
Properties of WT and mutant hERG K(+) channels expressed in neonatal mouse cardiomyocytes.Regulation and function of Cav3.1 T-type calcium channels in IGF-I-stimulated pulmonary artery smooth muscle cells.Calcineurin/NFAT signaling represses genes Vamp1 and Vamp2 via PMCA-dependent mechanism during dopamine secretion by Pheochromocytoma cells.Calcium channels and iron uptake into the heart.Identification of L- and T-type Ca2+ channels in rat cerebral arteries: role in myogenic tone developmentCaV1.2 sparklets in heart and vascular smooth muscleVoltage-gated calcium channel antagonists and traumatic brain injury.Calcineurin-dependent ion channel regulation in heart.1,4-dihydropyridines: the multiple personalities of a blockbuster drug family.Calcium Homeostasis and Ionic Mechanisms in Pulmonary Fibroblasts.Ca(2+) influx through L-type Ca(2+) channels and transient receptor potential channels activates pathological hypertrophy signalingResistance to pathologic cardiac hypertrophy and reduced expression of CaV1.2 in Trpc3-depleted mice.Calcium influx through Cav1.2 is a proximal signal for pathological cardiomyocyte hypertrophy.Ca(2+) channel blocker benidipine promotes coronary angiogenesis and reduces both left-ventricular diastolic stiffness and mortality in hypertensive rats.Fasudil, a Rho-kinase inhibitor, protects against excessive endurance exercise training-induced cardiac hypertrophy, apoptosis and fibrosis in rats.Role of the TRPM4 Channel in Cardiovascular Physiology and Pathophysiology.MicroRNA-204 Is Necessary for Aldosterone-Stimulated T-Type Calcium Channel Expression in Cardiomyocytes
P2860
Q33917022-9A7F5C92-A0DC-43AD-A397-8F1F9A8A51E6Q34718076-7D28AA43-7128-4D08-9184-A7360594203AQ35131056-453DA290-E0F2-416E-BEE0-B962934B763FQ35172888-08810D09-9DBA-405F-9F4A-DCBA3CF5FF11Q36528098-DD2BB618-6CDE-496B-AA59-B14468DBB2FDQ36919572-20F890C7-6AFE-42DE-9173-0F5884742291Q37277428-3BCBE815-9A1C-4492-84B6-AB3840CF5F55Q37315915-70AE9D2E-2FB4-4F5C-97D0-F59875CAED80Q38125687-EFB6306D-37E8-4675-A862-218683DFA6ABQ38382787-88FE37B7-9517-4606-B1F8-60DCAF8744B9Q42425047-95279E08-F564-4B0B-BD0E-40FAF4D13A44Q42497705-75E8425A-6315-4AD8-820C-9643E8F5FA13Q42592376-0F0050A5-34D2-47D0-BACC-FC94C5493BA1Q42709938-7D56C407-F3E6-4935-97A0-0F5175054CD3Q54543875-3F35C866-CEAE-4144-AA36-59F0833D34C8Q55495309-C0BF45FE-CF59-4F86-BF58-22B5546BCD09Q59138407-476B8676-DB5A-4399-B4B5-6446F1B306FB
P2860
T-type Ca2+ channel blockers prevent cardiac cell hypertrophy through an inhibition of calcineurin-NFAT3 activation as well as L-type Ca2+ channel blockers.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
T-type Ca2+ channel blockers p ...... L-type Ca2+ channel blockers.
@en
T-type Ca2+ channel blockers p ...... L-type Ca2+ channel blockers.
@nl
type
label
T-type Ca2+ channel blockers p ...... L-type Ca2+ channel blockers.
@en
T-type Ca2+ channel blockers p ...... L-type Ca2+ channel blockers.
@nl
prefLabel
T-type Ca2+ channel blockers p ...... L-type Ca2+ channel blockers.
@en
T-type Ca2+ channel blockers p ...... L-type Ca2+ channel blockers.
@nl
P2093
P1433
P1476
T-type Ca2+ channel blockers p ...... L-type Ca2+ channel blockers.
@en
P2093
Itsuo Kodama
Jong-Kook Lee
Kaichiro Kamiya
Keiko Miwa
Kenji Yasui
Mayumi Hojo
Mitsuru Horiba
Norihiro Ueda
Takao Muto
Tobias Opthof
P304
P356
10.1016/J.LFS.2007.11.010
P407
P577
2007-12-04T00:00:00Z